SVB Leerink analyst Andrew Berens maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Outperform and raises the price target from $33 to $37.
July 27, 7:07 AM
SVB Leerink analyst Andrew Berens upgrades Agios Pharmaceuticals (NASDAQ:AGIO) from Market Perform to Outperform and maintains $33 price target.
The Daily Biotech Pulse: AstraZeneca’s COVID-19 Vaccine As Effective As mRNA Shots, Humanigen’s Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth’s Alzheimer’s Program
July 13, 9:00 AM
Here's a roundup of top developments in the biotech space over the last 24 hours:
July 13, 3:38 AM
With the US stock futures trading slightly higher this morning on Wednesday after recording losses in the previous session, some of the stocks that may grab investor focus today are as follows:
June 27, 1:36 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
May 24, 7:16 AM
Goldman Sachs maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Sell and lowers the price target from $20 to $16.
May 17, 12:13 PM
Agios Pharmaceuticals Inc (NASDAQ:AGIO) will be letting go of 50 employees and shuffling its R&D leadership team to focus internal research…